Skip to main content

Tiziana Life Sciences Ltd

corporate_fare Company Profile

Tiziana Life Sciences Ltd

TLSA·NASDAQ·Life Sciences·CIK 0001723069

Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company listed on NASDAQ under the ticker TLSA. The company specializes in developing therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets targeting Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic lateral sclerosis. Tiziana Life Sciences Ltd. was originally incorporated in England and Wales on February 11, 1998, and changed its name to Tiziana Life Sciences plc in April 2014 following the acquisition of Tiziana Pharma Limited. On October 20, 2021, the company completed a reorganization, establishing Tiziana Life Sciences Ltd., a Bermuda-incorporated company, as the ultimate parent company. Its registered office is in Hamilton, Bermuda.

Tiziana Life Sciences Ltd (NASDAQ:TLSA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 30 items for TLSA at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Tiziana Reports Positive Phase 2 PET Imaging Data for Foralumab in Multiple System Atrophy
  • Tiziana Life Sciences Faces Going Concern, Secures $8.6M in Insider-Backed Offering to Fund Clinical Trials
  • Tiziana's Foralumab Shows Positive Preclinical Data for Long COVID Neuroinflammation
  • Tiziana Reports Positive Preclinical Data for Nasal Anti-CD3 in Age-Related Cognitive Decline
  • Tiziana Life Sciences Reports Positive Biomarker Data for Nasal Foralumab in MS, Showing Reduced Inflammation and Neuroprotection

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$18.43M
Diluted EPS
-$0.16
Op. Cash Flow
-$12.85M
Free Cash Flow
-$12.87M
Operating Income
-$21.13M
Cash & Equivalents
$4.01M
Debt / Equity
0.00×
Shares Outstanding
2.1M sh
Source: 20-F · filed 2026-05-01 · accession 0001213900-26-051015

Insider Transactions

TLSA files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

$0.6432 +3.64% today
52-week range · as of 2026-11-05 $0.5671 – $1.9
Market cap
$79.63M
Volume
231.9K (0.4× avg)
3-mo avg 542.2K
Live data · 2026-11-22 12:52 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed TLSA - Filings & News (Page 2)

TLSA
May 14, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.55
Real-time Price: $0.6432 info
Change: -$0.9069 (-59%) info
Market Cap: $79.629M info
TLSA
May 01, 2026, 5:00 PM EDT
Filing Type: 20-F
Importance Score:
8
Price at Filing: $1.34
Real-time Price: $0.6432 info
Change: -$0.6968 (-52%) info
Market Cap: $79.629M info
TLSA
Apr 16, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.29
Real-time Price: $0.6432 info
Change: -$0.6464 (-50%) info
Market Cap: $79.629M info
TLSA
Apr 01, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.22
Real-time Price: $0.6432 info
Change: -$0.5768 (-47%) info
Market Cap: $79.629M info
TLSA
Feb 25, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.34
Real-time Price: $0.6432 info
Change: -$0.6925 (-52%) info
Market Cap: $79.629M info
TLSA
Jan 21, 2026, 6:57 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $1.72
Real-time Price: $0.6432 info
Change: -$1.08 (-63%) info
Market Cap: $79.629M info
TLSA
Jan 20, 2026, 11:15 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.70
Real-time Price: $0.6432 info
Change: -$1.05 (-62%) info
Market Cap: $79.629M info
TLSA
Jan 16, 2026, 3:12 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.73
Real-time Price: $0.6432 info
Change: -$1.08 (-63%) info
Market Cap: $79.629M info
TLSA
Jan 16, 2026, 7:39 AM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $1.68
Real-time Price: $0.6432 info
Change: -$1.04 (-62%) info
Market Cap: $79.629M info
TLSA
Jan 16, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.69
Real-time Price: $0.6432 info
Change: -$1.05 (-62%) info
Market Cap: $79.629M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets